Baird Maintains Outperform on Laboratory Corp, Lowers Price Target to $244
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell maintains an Outperform rating on Laboratory Corp (NYSE:LH) but lowers the price target from $255 to $244.

April 26, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Baird maintains an Outperform rating on Laboratory Corp but lowers the price target from $255 to $244.
While the reduction in price target could suggest a slightly less optimistic view on the stock's future performance, the maintenance of an Outperform rating indicates continued confidence in the company's fundamentals. This mixed signal might lead to a neutral short-term impact on the stock price, as investors weigh the lowered price target against the analyst's overall positive outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100